Royal Bank of Canada Purchases 274,785 Shares of Acadia Healthcare Company, Inc. $ACHC

Posted by on Aug 12th, 2026

Royal Bank of Canada boosted its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report) by 7,896.1% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 278,265 shares of the company’s stock after purchasing an additional 274,785 shares during the period. Royal Bank of Canada owned about 0.30% of Acadia Healthcare worth $6,508,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. EverSource Wealth Advisors LLC increased its holdings in shares of Acadia Healthcare by 54.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after buying an additional 497 shares in the last quarter. Wells Fargo & Company MN boosted its holdings in shares of Acadia Healthcare by 208.9% in the 4th quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock worth $32,000 after acquiring an additional 1,510 shares in the last quarter. Bayforest Capital Ltd acquired a new stake in Acadia Healthcare during the 4th quarter valued at $52,000. Caitong International Asset Management Co. Ltd raised its position in Acadia Healthcare by 4,264.8% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 5,325 shares of the company’s stock valued at $76,000 after purchasing an additional 5,203 shares during the last quarter. Finally, Parallel Advisors LLC raised its position in Acadia Healthcare by 857.8% in the 1st quarter. Parallel Advisors LLC now owns 6,858 shares of the company’s stock valued at $160,000 after purchasing an additional 6,142 shares during the last quarter.

Acadia Healthcare Price Performance

Shares of ACHC stock opened at $31.10 on Wednesday. The firm has a market cap of $2.90 billion, a price-to-earnings ratio of -2.50, a PEG ratio of 10.31 and a beta of 0.64. Acadia Healthcare Company, Inc. has a 12 month low of $11.43 and a 12 month high of $35.83. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 1.20. The stock has a 50-day moving average price of $29.32 and a 200 day moving average price of $24.74.

Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last released its earnings results on Tuesday, July 28th. The company reported $0.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.35 by $0.03. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 6.19%. The company had revenue of $865.84 million for the quarter, compared to the consensus estimate of $844.19 million. During the same period in the prior year, the company posted $0.83 EPS. The company’s revenue was down .4% compared to the same quarter last year. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. Research analysts expect that Acadia Healthcare Company, Inc. will post 1.54 EPS for the current year.

Wall Street Analysts Forecast Growth

ACHC has been the topic of several research analyst reports. KeyCorp increased their target price on Acadia Healthcare from $30.00 to $40.00 and gave the stock an “overweight” rating in a report on Tuesday, July 14th. Royal Bank Of Canada lifted their price target on Acadia Healthcare from $28.00 to $31.00 and gave the company an “outperform” rating in a report on Monday, May 4th. TD Cowen increased their price objective on shares of Acadia Healthcare from $30.00 to $36.00 and gave the stock a “buy” rating in a report on Tuesday, July 14th. Barclays raised their price objective on shares of Acadia Healthcare from $25.00 to $32.00 and gave the company an “equal weight” rating in a research report on Thursday, July 30th. Finally, Raymond James Financial raised shares of Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 target price for the company in a research note on Monday, May 4th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have assigned a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $29.85.

Read Our Latest Research Report on Acadia Healthcare

About Acadia Healthcare

(Free Report)

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.

Featured Articles

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report).

Institutional Ownership by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.